Peapack Gladstone Financial Corp / ABT
Peapack Gladstone Financial Corp’s Abbott Laboratories Position
Does Peapack Gladstone Financial Corp own Abbott Laboratories (ABT)? Yes — 122.7K shares worth $13M (+0.16% of its 13F portfolio) as of Q1 2026, down from 141.2K shares the prior filed quarter.
Position Value
$13M
Q1 2026
Shares
122.7K
% of Portfolio
+0.16%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 122.7K | $13M | +0.16% |
| Q4 2025 | 141.2K | $18M | +0.22% |
| Q3 2025 | 149.6K | $20M | +0.26% |
| Q2 2025 | 162.5K | $22M | +0.31% |
| Q1 2025 | 139.3K | $18M | +0.27% |
| Q4 2024 | 127.1K | $14M | +0.21% |
| Q3 2024 | 129.8K | $15M | +0.21% |
| Q2 2024 | 131.3K | $14M | +0.21% |
| Q1 2024 | 134.4K | $15M | +0.24% |
| Q4 2023 | 135.0K | $15M | +0.25% |
| Q3 2023 | 132.5K | $13M | +0.24% |
| Q2 2023 | 133.0K | $15M | +0.26% |
| Q1 2023 | 124.5K | $13M | +0.24% |
| Q4 2022 | 127.1K | $14M | +0.27% |
| Q3 2022 | 127.7K | $12M | +0.25% |
| Q2 2022 | 115.3K | $13M | +0.29% |
| Q1 2022 | 116.7K | $14M | +0.27% |
| Q4 2021 | 117.7K | $17M | +0.31% |
| Q3 2021 | 118.2K | $14M | +0.29% |
| Q2 2021 | 108.4K | $13M | +0.30% |
| Q1 2021 | 108.1K | $13M | +0.33% |
| Q4 2020 | 103.6K | $11M | +0.34% |
| Q3 2020 | 103.3K | $11M | +0.41% |
| Q2 2020 | 104.1K | $10M | +0.38% |
| Q1 2020 | 104.6K | $8M | +0.39% |
| Q4 2019 | 103.5K | $9M | +0.36% |
| Q3 2019 | 103.0K | $9M | +0.37% |
| Q2 2019 | 110.1K | $9M | +0.40% |
| Q1 2019 | 110.2K | $9M | +0.40% |
| Q4 2018 | 108.8K | $8M | +0.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of ABT.